- Report
- June 2025
- 100 Pages
United States
From €5224EUR$5,950USD£4,565GBP
- Report
- May 2025
- 100 Pages
United States
From €5224EUR$5,950USD£4,565GBP
- Report
- April 2025
- 80 Pages
United States
From €4346EUR$4,950USD£3,798GBP
- Report
- October 2025
- 150 Pages
Middle East
From €5224EUR$5,950USD£4,565GBP
- Report
- September 2025
- 80 Pages
Middle East
From €5224EUR$5,950USD£4,565GBP
- Report
- August 2025
- 200 Pages
United States
From €2186EUR$2,490USD£1,911GBP
- Report
- May 2025
- 120 Pages
North America
From €4346EUR$4,950USD£3,798GBP
- Report
- December 2025
- 81 Pages
Europe
From €2854EUR$3,250USD£2,494GBP
- Report
- December 2025
- 71 Pages
Asia Pacific
From €2854EUR$3,250USD£2,494GBP
- Report
- September 2025
- 85 Pages
United States
From €3073EUR$3,500USD£2,686GBP
- Report
- August 2025
- 85 Pages
United States
From €3073EUR$3,500USD£2,686GBP
- Report
- May 2025
- 85 Pages
United States
From €3073EUR$3,500USD£2,686GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3397EUR$3,869USD£2,969GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3397EUR$3,869USD£2,969GBP
- Report
- June 2025
- 300 Pages
Europe
From €3397EUR$3,869USD£2,969GBP
- Report
- June 2025
- 250 Pages
United States
From €2449EUR$2,789USD£2,140GBP
- Report
- August 2025
- 123 Pages
North America
From €3511EUR$3,999USD£3,068GBP
- Report
- May 2025
- 172 Pages
Europe
From €3073EUR$3,500USD£2,686GBP
- Report
- April 2025
- 82 Pages
United States
From €3073EUR$3,500USD£2,686GBP
- Report
- February 2026
- 150 Pages
United States
From €3380EUR$3,850USD£2,954GBP
€4258EUR$4,850USD£3,721GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more